As shown in Fig. 5c, d, S1PR2 mRNA levels were significantly upregulated in the livers of human NASH patients and the WDSW-induced NASH mouse model. This evidence concerns the gene S1PR2 and metabolic dysfunction-associated steatohepatitis.